Are Accurins the cure for Aurora kinase inhibitors?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26865564.
- Also identified by DOI 10.1126/scitranslmed.aaf1417.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A nanoparticle formulation of an Aurora B inhibitor increases antitumor efficacy and reduces toxicity, which may be a precedent for the use of this technology with other small molecules (Ashton et al., this issue).
Medical subject headings
- Aurora Kinase B
- Aurora Kinases